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Table 1. The demographic- clinical characteristics and CT- echocardiographic
parameters of patients with and without RVD
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Age (years) 63.8  17.8 65.8  12.6 0.50
Gender n (F/M) 30/20 34/36 0.14
Hypertension n (%) 16 (32.0) 30 (42.9) 0.23
Systolic BP (mmHg) 110.3  17.3 111.3  24.2 0.81
Diastolic BP (mmHg) 70.5 11.8 69.8 13.1 0.77
Pulse (beats per minute) 94.8  15.5 91.0  15.3 0.24
Troponin (ng/mL) 0.65  1.8 2.21 8.2 0.74
Geneva Score 7.8  3.7 7.5  3.8 0.69
Wells Score 5.6  1.9 5.5  1.9 0.81
Intubation 0 (0) 2 (2.9) 0.15
Non-invasive mechanic ventilation 1 (2.0) 5 (7.1) 0.20
in-hospital mortality 2 (4.0) 4 (5.7) 0.72
Combined end- point 3 (6.0) 11 (15.7) 0.04
RV/LV Ratio 1.12  0.22 1.25  0.20 0.002
SVC axial diameter (mm) 20.2  3.6 22.5  3.4 0.001
PA axial diameter (mm) 29.7  4.2 33.3  5.5 <0.001
Ghanima 3.4  1.0 3.5  0.7 0.44
Miller 65.1  29.9 81.2  23.5 0.004
Qanadli 44.3  22.8 53.5  20.7 0.045
Mastora 29.9  17.3 37.6  16.3 0.029
LV-EDD (cm) 4.40.4 4.40.5 0.55
LV-ESD (cm) 2.60.5 2.70.5 0.76
EF (%) 59.75.7 59.63.7 0.91
PAP systolic (mmHg) 39.713.7 58.614.7 <0.001
RV Sm cm/s 13.93  2.65 11.803.69 0.07
BP: Blood Pressure, EDD: End diastolic diameter, ESD: End Systolic diameter, EF:Ejection fraction, IQR:
Inter quartile range, LV:Left Ventricule, PA:Pulmonary Artery, PAP: Pulmonary artery pressure, RV: Right
Ventricule, RV Sm: Right ventricular myocardial systolic velocity, SVC: Superior Vena Cava
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Aim: Obesity, a major cluster of risk factors for cardiovascular diseases, shows
increasing prevalence worldwide. The risk of obesity is determined not only by
speciﬁc genotypes but also by signiﬁcant gene-gene interactions. Several studies have
established associations of both apolipoprotein A4 (APOA4) gene variants and fat
mass and an obesity associated (FTO) gene variants with blood lipid levels and
obesity. Our aim was to explore the synergistic contribution of the two poly-
morphisms: T347S of the APOA4 gene and rs1421085 of the FTO gene to obesity risk
in a Turkish adult population.
Methods: We investigated a possible interaction between these two genes on the risk
for the obesity, using data from the TARF study (1512 men and women aged
50.0612.01 years). Genotyping was achieved by high throughput systems as Real-
Time PCR LC480 and ABI-7900HT. Statistical analysis was performed by condi-
tional multiple regression models.
Results: APOA4 T347S and FTO rs1421085 polymorphism combinations showed
a nominal gene-gene interaction (p values 0.014 and 0.030 respectively) on obesity.
Logistic regression analyses of T347S ve rs1421085 polymorphisms, after adjustment
for age and gender these interactions were also showed (p for interaction ¼0.007 and
¼0.027, respectively).
Conclusion: A synergistic effect between polymorphism T347S of the APOA4 gene
and rs1421085 of the FTO gene for obesity risk was found in Turkish adult
population.
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Aim: Recent studies found that Lipoprotein(a) [Lp (a)] levels were lower in patients
with type 2 diabetes than the non-diabetics. Little is known about the genetic deter-
minants for Lp(a) levels in diabetic patients, and it remains unclear whether elevated
Lp(a) levels may causally affect cardiovascular disease risk in the diabetic patients.
LPA encodes apolipoprotein(a), and rs10455872 polymorphism in the LPA locus is
associated with Lp(a) levels and cardiovascular risk factors. In this study, therefore,
we aimed to investigate the effects of the rs10455872 polymorphism in the LPA gene
locus on Lp(a) levels and risk factors for type 2 diabetes in the Turkish population.
Method: We examined one single-nucleotide polymorphism (SNP) in LPA gene in
the Turkish Adult Risk Factor (TARF) Study DNA bank which has been established
between 2004-2010 years. The sample was comprised of 2252 Turkish adults. Gen-
otyping was performed by high throughput system, Real-Time PCR LC480 device.
The association between biochemical, clinical parameters and the polymorphism have
been analyzed using SPSS software. For continuous variables, ANOVA T-test was
used, whereas X2 analysis was performed for categoricals.
Results: In this study, the ﬁrst one to examine the rs10455872 polymorphism of the
LPA gene in the Turkish population. The distribution of the LPA rs10455872 poly-
morphism in this adult population was 97% (n¼2185), 3% (n¼66) and 0% (n¼1) for
the AA, AG and GG genotypes, respectively. The rs10455872 in LPA gene locus was
most strongly associated with higher Lp(a) levels (p<0.0001) in Turkish adults. In
contrast, the LPA rs10455872 AG genotype was correlated lower HOMA index and
insulin levels in Turkish adults (p<0.01). However, no signiﬁcant relationship was
found for the LPA rs10455872 polymorphism with type 2 diabetes in men and women.
Conclusion: The LPA rs10455872 AG genotype appears to be a risk factor against
coronary heart disease by increasing the Lp(a). In contrast, AG genotype of the LPA
gene independently confers protectiveness for type 2 diabetes by decreasing the
HOMA index and insulin levels in Turkish adults.LS C53
